Triton Acquires Majority Stake in Atnahs

August 8, 2019

Funds advised by Triton Partners have acquired a majority stake in Atnahs, a UK-based specialty pharmaceutical business that acquires, develops and markets mature branded medicines. Atnahs operates a portfolio of over 800 SKUs across more than 130 markets; terms of the transaction were not disclosed.

Buyers
Triton (funds advised by Triton Partners)
Targets
Atnahs
Industry
Pharmaceuticals
Location
Essex, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.